Plasma Methoxytyramine: A Novel Biomarker of Metastatic Pheochromocytoma and Paraganglioma in Relation to Established Risk Factors of Tumour Size, Location and SDHB Mutation Status

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2011.07.016

Related search